Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. This evidence concerns the gene SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4.